Skip to main content
Midas Edge

Anebulo Pharmaceuticals, Inc.

For the period ended Jul 23, 2025. Filed Jul 23, 2025.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Jul 23, 2025 · Filed Jul 23, 2025

Use the contents to explore the available documents and sections.

ANEB$0.34-1.8%Stored close · as of Jul 8, 2026
See the whole filing, with its images and exhibits
Contents

EX-99.1 · PROXY STATEMENT

PROXY STATEMENT AND OTHER REQUIRED MATERIALS, INCLUDING A PRELIMINARY SCHEDULE 13E-3, WITH THE SEC CONCERNING THE PROPOSED STOCK SPLIT. THE COMPANY INTENDS TO FILE A DEFINITIVE PROXY STATEMENT, AND OTHER REQUIRED MATERIALS, INCLUDING A SCHEDULE 13E-3, WITH THE SEC. A COPY OF ALL FINAL PROXY MATERIALS WILL BE SENT TO STOCKHOLDERS PRIOR TO A

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.